Ms. NTUMBA LOBO | Physical Chemistry | Best Researcher Award

Published on by Chemistry Awards

Ms. NTUMBA LOBO | Physical Chemistry | Best Researcher Award

Ms. NTUMBA LOBO | Physical Chemistry | PhD student at NAGOYA INSTITUTE OF TECHNOLOGY, Japan

Ntumba Lobo, a Congolese researcher, is a Ph.D. student and research assistant at Nagoya Institute of Technology, Japan. She specializes in semiconductor materials, focusing on carrier recombination effects in perovskites. She holds a Master’s degree from Shibaura Institute of Technology, Japan, in hydrogen storage materials, and an M.Sc. in Nuclear Physics from Addis Ababa University, Ethiopia. With experience in international collaborations, she was an exchange researcher at Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany. Ntumba has participated in several scientific conferences and published extensively in high-impact journals. She has also held teaching and research positions, including at the University of Kinshasa and the Centre Régional de Recherche Nucléaire de Kinshasa. Her work contributes significantly to materials science and renewable energy applications.

Professional Profile :         

Google Scholar

Orcid

Scopus  

Summary of Suitability for Award:

Ntumba Lobo is an exceptional researcher with a strong multidisciplinary background in semiconductor materials, energy storage, and nuclear physics. Her Ph.D. research at Nagoya Institute of Technology, Japan, focuses on metal halide perovskites, lithium tantalate, and carrier dynamics, contributing significantly to the development of advanced semiconductor materials. She has demonstrated excellence in research through multiple international collaborations, including an exchange program at Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany. Her expertise in material characterization techniques such as Time-Resolved Photoluminescence (TRPL), Scanning Electron Microscopy (SEM), and X-ray Diffraction (XRD) has led to high-impact publications and conference presentations. Ntumba Lobo’s extensive research contributions, global collaborations, and expertise in semiconductor and energy materials make her a strong candidate for the “Best Researcher Award.” Her work is not only innovative but also has a significant impact on the future of optoelectronic devices and sustainable energy solutions. Her dedication to scientific excellence, combined with her ability to work across disciplines, positions her as a deserving recipient of this prestigious recognition.

🎓Education:

Ntumba Lobo is currently pursuing a Ph.D. in Science and Engineering at Nagoya Institute of Technology, Japan, specializing in semiconductor materials (expected completion in September 2025). She was an exchange student at i-MEET, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany, in 2022, where she worked on single and polycrystal semiconductor materials. She obtained a Master’s degree in Science and Engineering from Shibaura Institute of Technology, Japan (2018-2020), focusing on energy storage materials. Before that, she completed an M.Sc. in Nuclear Physics from Addis Ababa University, Ethiopia (2014-2016), with a dissertation on nuclear fusion reactions. Her academic journey began with a B.Sc. (Honors) in Physics from the University of Kinshasa, Democratic Republic of the Congo (2012), where she contributed to non-destructive characterization of reinforced concrete using ultrasound methods. Her diverse educational background in physics, material science, and engineering has equipped her with expertise in semiconductor research and energy materials.

🏢Work Experience:

Ntumba Lobo has extensive experience in research and teaching. Since 2020, she has been a Research Assistant at Nagoya Institute of Technology, working on semiconductor materials and device characterization. She has completed multiple internships, including at OSM Group Co., Ltd. (Japan, 2019) and For Delight Co. Ltd. (Japan, 2018), where she gained industry exposure. Her research career started with an internship at the Centre Régional de Recherche Nucléaire de Kinshasa (2016-2017) in nuclear physics. She also worked as a Teaching Assistant at the University of Kinshasa (2013-2014) and taught physics, scientific drawing, and technology at Liziba High School (2012-2013). Her hands-on expertise in material characterization techniques, including Scanning Electron Microscopy (SEM), X-ray Diffraction (XRD), and photoconductivity measurements, has contributed to multiple high-impact publications. Her professional experience spans academic, industrial, and research institutions, making her a well-rounded scientist in semiconductor and energy materials.

🏅Awards: 

Ntumba Lobo has been recognized for her contributions to material science and semiconductor research. She received funding for an exchange research program at Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany (2022), where she worked on advanced semiconductor materials. Her research on energy storage materials during her Master’s at Shibaura Institute of Technology was highly appreciated. She has presented her work at prestigious conferences, including the 16th International Symposium on Metal-Hydrogen Systems (China, 2018) and the Solid-State Devices and Materials Conference (Japan, 2023). She also participated in specialized training programs such as the Summer School on Space Weather in Kinshasa (2011) and Advanced Python Programming and Geographic Information Systems training in Addis Ababa (2016). Her continuous engagement in international research collaborations and conferences showcases her commitment to scientific advancement.

🔬Research Focus:

Ntumba Lobo’s research focuses on semiconductor materials, particularly metal halide perovskites and their carrier dynamics. She investigates surface recombination, carrier lifetime, and trapping effects in single and polycrystalline materials using techniques like Microwave Photoconductivity Decay (µPCD) and Time-Resolved Photoluminescence (TRPL). Her work extends to lithium tantalate and its photoconductance properties. She has also contributed to the field of hydrogen storage materials, analyzing the effects of TiO₂, Nb₂O₅, and TiH₂ catalysts on magnesium hydride. Additionally, her expertise in nuclear physics has allowed her to explore neutron-induced reactions and fusion mechanisms. By integrating her knowledge in physics, materials science, and engineering, she aims to develop efficient, stable, and high-performance materials for energy storage and semiconductor applications. Her research is pivotal in advancing next-generation optoelectronic devices and sustainable energy solutions.

Publication Top Notes:

Stability investigation of the γ-MgH₂ phase synthesized by high-energy ball milling

Citations: 27

Stable quasi-solid-state zinc-ion battery based on the hydrated vanadium oxide cathode and polyacrylamide-organohydrogel electrolyte

Citations: 13

Trapping effects and surface/interface recombination of carrier recombination in single- or poly-crystalline metal halide perovskites

Citations: 9

Study of ²⁰Ne Induced Reaction in ⁵⁹Co: Incomplete and Complete Fusion

Citations: 3

Effect of TiO₂ + Nb₂O₅ + TiH₂ Catalysts on Hydrogen Storage Properties of Magnesium Hydride

Citations: 2

La Super Symétrie en Physique Quantique

Citations: 1

Mitigation of carrier trapping effects on carrier lifetime measurements with continuous-wave laser illumination for Pb-based metal halide perovskite materials

Transport and business improvement in the province of South-Ubangi (Democratic Republic of the Congo)

 

Dr. Diba Kadivar | Inorganic Chemistry | Best Researcher Award

Published on by Chemistry Awards

Dr. Diba Kadivar | Inorganic Chemistry| Best Researcher Award

Dr. Diba Kadivar | Inorganic Chemistry| Ph. D. graduate in inorganic chemistry at chemistry and chemical engineering research center of iran , Iran

Dr. Diba Kadivar is a Ph.D. graduate in Inorganic Chemistry with extensive expertise in anticancer platinum complexes. She has been serving as a technical assistant at the Iranian Food and Drug Administration (IFDA) for over eight years, contributing to pharmaceutical research and regulatory affairs. Dr. Kadivar has conducted significant studies on the synthesis, characterization, and biological activity of novel platinum-based anticancer agents. Her research focuses on the impact of geometric isomerism and aliphatic N-substituted glycine derivatives on platinum complexes’ pharmacological properties. She has published multiple papers in reputed journals and actively collaborates on cancer cell line studies. Passionate about innovative drug discovery, she has contributed to the development of metal-based nanocomplexes for potential therapeutic applications. Dr. Kadivar remains committed to advancing medicinal inorganic chemistry through her research and collaborations, aiming to enhance the effectiveness of anticancer therapies while minimizing side effects.

Professional Profile :         

Google Scholar

Orcid

Scopus  

Summary of Suitability for Award:

Dr. Diba Kadivar is a distinguished researcher in inorganic chemistry, specializing in anticancer platinum complexes. With a Ph.D. in inorganic chemistry and eight years of experience as a technical assistant at the Iranian Food and Drug Administration (IFDA), she has made notable contributions to the development of novel platinum-based anticancer agents. Her research focuses on the impact of geometric isomerism and the role of aliphatic N-substituted glycine derivatives in enhancing the biological activities of platinum complexes. She has published in reputable journals such as Elsevier and the Iranian Quarterly Journal of Chemical Communications, with a citation index of 18. Dr. Diba Kadivar’s innovative research on platinum-based anticancer drugs, scientific contributions, and expertise in inorganic medicinal chemistry make her highly suitable for the “Best Researcher Award.” Her work advances cancer treatment strategies, and her publications demonstrate scientific excellence and impact in medicinal chemistry.

🎓Education:

Dr. Diba Kadivar pursued her doctoral studies in Inorganic Chemistry, specializing in metal-based drug development and anticancer platinum complexes. Her academic journey has been marked by a strong foundation in medicinal chemistry, with a keen interest in exploring the role of isomerism in drug efficacy. During her Ph.D., she conducted extensive research on platinum complexes with glycine derivatives, focusing on their interaction with DNA and anticancer properties. Her work involved molecular docking, dynamic simulations, and in-vitro studies to evaluate the pharmacological potential of these compounds. Through her research, she contributed to the field of coordination chemistry and its applications in medicine. She has actively participated in international conferences, presenting her findings on novel platinum-based therapies. With a passion for drug discovery, Dr. Kadivar continues to apply her expertise in chemistry to enhance the effectiveness of anticancer agents.

🏢Work Experience:

Dr. Diba Kadivar has accumulated over eight years of professional experience as a technical assistant at the Iranian Food and Drug Administration (IFDA). In this role, she has been actively involved in regulatory affairs, pharmaceutical analysis, and drug quality control, ensuring the safety and efficacy of therapeutic compounds. Alongside her administrative responsibilities, she has played a vital role in cancer research, working in laboratory settings to study platinum-based anticancer agents. Her expertise extends to working with cancer and normal cell lines, contributing to drug screening and cytotoxicity assays. Additionally, she has been involved in synthesizing and characterizing novel platinum complexes, focusing on their pharmacological interactions. Dr. Kadivar also collaborates with academic institutions and research centers, aiming to bridge the gap between regulatory science and drug discovery. Her hands-on experience in both research and regulatory affairs makes her a key contributor to pharmaceutical advancements in Iran.

🏅Awards: 

Dr. Diba Kadivar has been recognized for her contributions to inorganic and medicinal chemistry, particularly in the field of platinum-based anticancer research. She has received accolades for her pioneering work on the role of geometric isomerism in anticancer drug efficacy. Her research has been acknowledged at national and international scientific conferences, where she has been invited as a speaker and presenter. She has also played a key role in regulatory initiatives at the Iranian Food and Drug Administration, contributing to drug quality assurance and research-based policy-making. Additionally, her publications in esteemed journals such as Elsevier and the Iranian Quarterly Journal of Chemical Communications have received notable citations, highlighting her impact on the field. Dr. Kadivar’s dedication to advancing cancer therapy and pharmaceutical sciences continues to earn her recognition among her peers, further solidifying her reputation as an innovative researcher in medicinal inorganic chemistry.

🔬Research Focus:

Dr. Diba Kadivar’s research primarily revolves around the synthesis, characterization, and biological evaluation of platinum-based anticancer complexes. She investigates the impact of geometric isomerism on drug efficacy, focusing on how structural variations influence DNA interactions and cytotoxicity. Her studies explore novel ligand designs, particularly aliphatic N-substituted glycine derivatives, to enhance the pharmacological properties of platinum complexes. In addition to drug synthesis, she conducts in-vitro studies on cancer and normal cell lines to assess the cytotoxic potential of these compounds. She is also involved in molecular docking and dynamic simulations to predict drug interactions at the molecular level. Furthermore, she has worked on calcium, magnesium, copper, and zinc glycine edible nanocomplexes, aiming to develop biocompatible metal-based therapies. Through her interdisciplinary approach, Dr. Kadivar contributes to bridging chemistry and medicine, paving the way for new, targeted anticancer treatments with improved therapeutic outcomes.

Publication Top Notes:

Pharmacological properties of some 3-substituted indole derivatives, a concise overview

Authors: K. Nikoofar, D. Kadivar, S. Shirzadnia

Citations: 13

Year: 2014

Effect of geometric isomerism on the anticancer property of new platinum complexes with glycine derivatives as asymmetric N, O donate ligands against human cancer

Authors: D. Kadivar, M. E. Moghadam, B. Notash

Citations: 5

Year: 2024

Novel anticancer agents, Pt complex with 1-pyrrolidineacetic acid ligand: Synthesis, biological activity, DNA interaction, molecular docking, and dynamic study

Authors: D. Kadivar, M. E. Moghadam, M. Rezaeisadat

Year: 2025